PALISADE BIO, INC. Capital Expenditures
PALISADE BIO, INC. (PALI) reported Capital Expenditures of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-24.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2025-03-24
- PALISADE BIO, INC. payments to acquire property, plant, and equipment for the quarter ending 2024-12-31 was $0.00.
- PALISADE BIO, INC. payments to acquire property, plant, and equipment for the quarter ending 2024-09-30 was $0.00.
- PALISADE BIO, INC. payments to acquire property, plant, and equipment for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- PALISADE BIO, INC. payments to acquire property, plant, and equipment for the quarter ending 2023-09-30 was $0.00.
- PALISADE BIO, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- PALISADE BIO, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $4.00K, a 60.00% decline from fiscal 2022.
- PALISADE BIO, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $10.00K.
- PALISADE BIO, INC. payments to acquire property, plant, and equipment for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $0.00 derived: sum of 2 quarters · filed 2025-03-24 | $0.00 10-K · filed 2025-03-24 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-12 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $0.00 derived: sum of 2 quarters · filed 2025-03-24 | $4.00K 10-K · filed 2025-03-24 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $4.00K 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $4.00K 10-Q · filed 2024-08-12 | |||
| 2022-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $10.00K derived: sum of 2 quarters · filed 2024-03-26 | $10.00K 10-K · filed 2024-03-26 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-10 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $0.00 derived: sum of 2 quarters · filed 2023-03-22 | $0.00 10-K · filed 2023-03-22 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 10-Q · filed 2021-11-12 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-23 | |||
| 2020-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $0.00 derived: sum of 2 quarters · filed 2022-03-17 | $6.00K 10-K · filed 2022-03-17 | |
| 2020-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $5.00K 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $6.00K 10-Q · filed 2021-08-23 | |||
| 2018-12-31 | $1.71K 10-K · filed 2020-03-27 | |||
| 2017-12-31 | $408.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $1.73K derived: sum of 2 quarters · filed 2019-03-22 | $11.40K 10-K · filed 2019-03-22 | |
| 2017-09-30 | $1.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $10.99K 10-Q · filed 2018-11-14 | ||
| 2017-06-30 | $9.67K 10-Q · filed 2018-08-13 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $0.00 derived: sum of 2 quarters · filed 2018-04-02 | $83.49K derived: sum of 3 quarters · filed 2018-04-02 | $98.09K 10-K · filed 2018-04-02 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $83.49K derived: sum of 2 quarters · filed 2017-11-08 | $98.09K 10-Q · filed 2017-11-08 | $146.15K derived: sum of 4 quarters · filed 2017-11-08 |
| 2016-06-30 | $83.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $98.09K 10-Q · filed 2017-08-08 | $146.15K derived: sum of 3 quarters · filed 2017-08-08 | $178.34K derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-03-31 | $14.60K 10-Q · filed 2017-05-10 | $62.66K derived: sum of 2 quarters · filed 2017-05-10 | $94.85K derived: sum of 3 quarters · filed 2017-05-10 | $174.82K derived: sum of 4 quarters · filed 2017-05-10 |
| 2015-12-31 | $48.06K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-23 | $80.25K derived: sum of 2 quarters · filed 2017-03-23 | $160.22K derived: sum of 3 quarters · filed 2017-03-23 | $176.27K 10-K · filed 2017-03-23 |
| 2015-09-30 | $32.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $112.16K derived: sum of 2 quarters · filed 2016-11-08 | $128.21K 10-Q · filed 2016-11-08 | $163.94K derived: sum of 4 quarters · filed 2016-11-08 |
| 2015-06-30 | $79.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $96.02K 10-Q · filed 2016-08-11 | $131.74K derived: sum of 3 quarters · filed 2016-08-11 | $158.82K derived: sum of 4 quarters · filed 2016-08-11 |
| 2015-03-31 | $16.05K 10-Q · filed 2016-05-09 | $51.77K derived: sum of 2 quarters · filed 2016-05-09 | $78.85K derived: sum of 3 quarters · filed 2016-05-09 | $112.86K derived: sum of 4 quarters · filed 2016-05-09 |
| 2014-12-31 | $35.72K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $62.80K derived: sum of 2 quarters · filed 2016-03-14 | $96.81K derived: sum of 3 quarters · filed 2016-03-14 | $207.89K 10-K · filed 2016-03-14 |
| 2014-09-30 | $27.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $61.08K derived: sum of 2 quarters · filed 2015-11-09 | $172.17K 10-Q · filed 2015-11-09 | $178.59K derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | $34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $145.09K 10-Q · filed 2015-08-10 | $151.51K derived: sum of 3 quarters · filed 2016-03-14 | $265.06K derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-03-31 | $111.09K 10-Q · filed 2015-05-08 | $117.51K derived: sum of 2 quarters · filed 2016-03-14 | $231.06K derived: sum of 3 quarters · filed 2016-03-14 | $234.79K derived: sum of 4 quarters · filed 2016-03-14 |
| 2013-12-31 | $6.42K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $119.97K derived: sum of 2 quarters · filed 2016-03-14 | $123.71K derived: sum of 3 quarters · filed 2016-03-14 | $125.36K 10-K · filed 2016-03-14 |
| 2013-09-30 | $113.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $117.28K derived: sum of 2 quarters · filed 2014-11-07 | $118.94K 10-Q · filed 2014-11-07 | $127.95K derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-06-30 | $3.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $5.39K 10-Q · filed 2014-08-08 | $14.41K derived: sum of 3 quarters · filed 2015-03-16 | $15.00K derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-03-31 | $1.66K 10-Q · filed 2014-05-12 | $10.67K derived: sum of 2 quarters · filed 2015-03-16 | $11.27K derived: sum of 3 quarters · filed 2015-03-16 | $40.88K derived: sum of 4 quarters · filed 2015-03-16 |
| 2012-12-31 | $9.02K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $9.61K derived: sum of 2 quarters · filed 2015-03-16 | $39.22K derived: sum of 3 quarters · filed 2015-03-16 | $39.22K 10-K · filed 2015-03-16 |
| 2012-09-30 | $593.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $30.20K derived: sum of 2 quarters · filed 2013-11-12 | $30.20K 10-Q · filed 2013-11-12 | $39.52K derived: sum of 4 quarters · filed 2014-03-10 |
| 2012-06-30 | $29.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $29.61K 10-Q · filed 2013-08-08 | $38.93K derived: sum of 3 quarters · filed 2014-03-10 | $44.06K derived: sum of 4 quarters · filed 2014-03-10 |
| 2012-03-31 | $0.00 10-Q · filed 2013-05-10 | $9.32K derived: sum of 2 quarters · filed 2014-03-10 | $14.45K derived: sum of 3 quarters · filed 2014-03-10 | $146.24K derived: sum of 4 quarters · filed 2014-03-10 |
| 2011-12-31 | $9.32K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10 | $14.45K derived: sum of 2 quarters · filed 2014-03-10 | $146.24K derived: sum of 3 quarters · filed 2014-03-10 | $196.41K 10-K · filed 2014-03-10 |
| 2011-09-30 | $5.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $136.92K derived: sum of 2 quarters · filed 2012-11-09 | $187.09K 10-Q · filed 2012-11-09 | $235.43K derived: sum of 4 quarters · filed 2012-11-09 |
| 2011-06-30 | $131.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $181.96K 10-Q · filed 2012-08-09 | $230.30K derived: sum of 3 quarters · filed 2012-08-09 | $231.89K derived: sum of 4 quarters · filed 2012-08-09 |
| 2011-03-31 | $50.17K 10-Q · filed 2012-05-09 | $98.51K derived: sum of 2 quarters · filed 2012-05-09 | $100.10K derived: sum of 3 quarters · filed 2012-05-09 | |
| 2010-12-31 | $48.34K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $49.93K derived: sum of 2 quarters · filed 2012-03-30 | $76.32K 10-K · filed 2012-03-30 | |
| 2010-09-30 | $1.59K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-09 | $27.98K 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | $26.39K 10-Q/A · filed 2011-09-23 | |||
| 2009-12-31 | $88.38K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |